| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.1 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.1 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.1 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.1 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.1 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |